Latest Updates
In The News
Stay informed with the latest breakthroughs, company updates, and industry insights from Enquyst Technologies.
October 2025
A team led by NIIMBL selected to receive a $10.5M funding award from the Gates Grand Challenge Program to advance exceptionally low-cost monoclonal antibody manufacturing. As a key partner, Enquyst Technologies will use its portion of the funding award to scale-up its IPP technology.
July 2025
Enquyst Technologies receives an initial Qualified Investment of $3 million from the NJ Innovation Evergreen Fund through an application for co-investment submitted by the New York City-based venture capital firm Eckuity Capital.
August 2025
Enquyst Technologies expands its operations into New Jersey, opening new R&D laboratory space at the NJ Bioscience Center.
April 2024
Enquyst awarded a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) for the agency’s Project Call 7.1: Technologies for intensified processing of therapeutic proteins. The grant provides funding to Enquyst to advance its IPP technology in collaboration with UMass Lowell and corporate sponsors, LONZA Biologics and MilliporeSigma.
April 2023
Enquyst’s CSO, Dr. Jason Criscione, featured in TechBullion HealthTech article.
Events
Venture Summit West 2025
Silicon Valley, CA
Enquyst Technologies was selected as a Top Innovator in Biotech and Dr. Jason Criscione, Chief Scientific Officer, presented the company’s innovative IPP technology to healthcare investors.
Biotech Showcase 2025
San Francisco, CA
Dr. Jason Criscione, Chief Scientific Officer of Enquyst Technologies presented at the new TechBio Showcase at Biotech Showcase to provide an update on the company's innovative IPP technology and its transformative impact on biologics manufacturing.
Cell and Gene Therapy Summit 2024
Newton, MA
Dr Jason Criscione presented on the application of Enquyst’s innovative IPP technology in the manufacture of viral vectors at the Cell and Gene Therapy Summit.
NIIMBL: 2024 NATIONAL MEETING
Washington, D.C.
Enquyst selected as one of twenty small-to-medium manufacturing (SMM) company to present a lightning pitch and poster showcasing its process analytical technologies.
Biotech Showcase 2024
San Francisco, CA
Dr. Jason Criscione, Chief Scientific Officer of Enquyst Technologies presented at Biotech Showcase to provide an update on the company's innovative IPP technology and its transformative impact on biologics manufacturing.
Bioprocess International 2023 (East)
Boston, MA
Enquyst selected to give a presentation at the Innovation Start-up Showcase at Bioprocess International 2023.
NIIMBL: 2023 NATIONAL MEETING
Washington, D.C.
Enquyst selected as one of twenty small-to-medium manufacturing (SMM) company to present a lightning pitch and poster showcasing its IPP technology.
BIO 2023
Boston, MA
Enquyst selected to give a company presentation at BIO 2023.
Start-up Stadium at BIO 2023
Boston, MA
Enquyst named a finalist at the Start-up Stadium pitch contest at BIO 2023.
Interphex 2023
New York City, NY
Enquyst comes out of stealth mode to present and exhibit its patented IPP technology at Innophex, the innovation segment of Interphex.